We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Debiopharm and Moffitt Cancer Center Sign Development and Commercialization Agreement for Small Molecule

News   Jun 22, 2009

 
Debiopharm and Moffitt Cancer Center Sign Development and Commercialization Agreement for Small Molecule
 
 
 

RELATED ARTICLES

First-degree Relatives of Blood Cancer Patients at Greater Risk

News

Those with a parent, sibling or child affected by blood cancer are more likely to be diagnosed with the disease, according to a new study.

READ MORE

Gene Therapy for Niemann-Pick Type a Diseases Moves Forward

News

Research shows that gene replacement therapy for Niemann-Pick type A disease is safe for use in nonhuman primates and has therapeutic effects in mice.

READ MORE

New Method to Synthesize and Screen Macrocyclic Compounds

News

Scientists at EPFL have found a way to generate libraries of more than 9,000 of macrocyclic molecules below 1 KDa, all with high structural diversity.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE